Работы, цитирующие эту работу

Работ: 2

Работа: Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

1. DERN CONTROL POINT INHIBITORS AND THEIR POSSIBILITIES FOR THE THERAPY OF METASTATIC UROTELIAL CANCER

   M.N. Tillyashajhov, С В Камышов, E. P. Bojko

   СтатьяBladder and Urothelial Cancer TreatmentsEurasianUnionofScientists2020Цитирований: 0

   ABIABI:AkademIndex/openalex/2020.article.002791

2. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

   Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

   СтатьяCancer Immunotherapy and BiomarkersClinical & Translational Oncology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.002768